Bekunis Herbal Tablets
Natural health product licensed in Canada
- Licence holder
- Roha Arzneitmittel GmbH
- NPN or DIN-HM
- 80003825
- Status
- Active licence
- Licence date
- 1 August 2007
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- TPD Cat IV/LS
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cassia angustifolia Potency : 20 mg sennosides B | 200 mg | Not calculated |
Non-medicinal ingredients
Lactose, Anhydrous, Gélatine, Cellulose, microcristalline, Stéarate de magnésium, Carboxyméthylcellulose de sodium, Methylated silicon dioxide, Palmitic Acid, Monton wax, Carbonate de calcium, Talc, Dioxyde de titane, Poly(sorbate) 80, Poly(methacrylic acid, ethyl acrylate) 1:1, Polyethylacrylate, glucose syrup, Saccharose, Poly(éthylène glycol), Acide stéarique, gomme acacia
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 12 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Relief of occasional constipation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Overuse or prolonged use may result in dependency of the intestinal function.
- Contre-indications
Do not use in presence of unexplained abdominal pain, nausea, fever or vomiting since this refers to signs of appendicitis or inflamed bowel. Do not take within 2 hours of another medicine as the effect of the other medicine could be reduced. Consult a health care practitioner before use if you are pregnant or breastfeeding. Do not take any type of laxative for more than one week without consulting a health care practitioner unless your physician has ordered a special schedule for you.
Source
Official Health Canada record, licence 80003825
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.